TAP’s Prevacid PAP Is Available To Part D Beneficiaries; Bristol-Myers Squibb To Focus On Coalition Approach
This article was originally published in The Pink Sheet Daily
Executive Summary
TAP extended its Prevacid prescription assistant program to Medicare drug plan enrollees whose household income is between 135% and 200% of the federal poverty level.